Abstract
Background: The annualized recurrent stroke rate in patients with Embolic Stroke of Undetermined Source (ESUS) under antiplatelet therapy is around 4.5%. Only a fraction of these patients will develop atrial fibrillation (FA), to which a stroke can be attributed retrospectively. The challenge is to identify patients at risk of occult AF during follow-up.
Objective: This work aims to determine clinical factors and electrocardiographic and ultrasound parameters that can predict occult AF in patients with ESUS and build a simple predictive score applicable worldwide.
Methods: This is a single-center, registry-based retrospective study conducted at the stroke unit of Sahloul University Hospital, Sousse, Tunisia, between January 2016 and December 2020. Consecutive patients meeting ESUS criteria were monitored for a minimum of one year, with a standardized follow-up consisting of outpatient visits, including ECG every three months and a new 24-hour Holter monitoring in case of palpitations. We performed multivariate stepwise regression to identify predictors of new paroxysmal AF among initial clinical, electrocardiographic (ECG and 24-hour Holter monitoring) and echocardiographic parameters. The coefficient of each independent covariate of the fitted multivariable model was used to generate an integerbased point-scoring system.
Results: Three hundred patients met the criteria for ESUS. Among them, 42 (14%) patients showed at least one episode of paroxysmal AF during a median follow-up of two years. In univariate analysis, age, gender, coronary artery disease, history of ischemic stroke, higher NIHSS at admission and lower NIHSS at discharge, abnormal P-wave axis, prolonged P-wave duration, premature atrial contractions (PAC) frequency of more than 500/24 hours, and left atrial (LA) mean area of more than 20 cm2 were associated with the risk of occurrence of paroxysmal AF. We proposed an AF predictive score based on (1.771 x NIHSS score at admission) + (10.015 x P-wave dispersion; coded 1 if yes and 0 if no) + (9.841x PAC class; coded 1 if ≥500 and 0 if no) + (9.828x LA class surface; coded 1 if ≥20 and 0 if no) + (0.548xNIHSS score at discharge) + 0.004. A score of ≥33 had a sensitivity of 76% and a specificity of 93%.
Conclusion: In this cohort of patients with ESUS, NIHSS at both admission and discharge, Pwave dispersion, PAC≥500/24h on a 24-hour Holter monitoring, and LA surface area≥20 cm2 provide a simple AF predictive score with very reasonable sensitivity and specificity and is applicable almost worldwide. An external validation of this score is ongoing.
[http://dx.doi.org/10.1159/000441106] [PMID: 26505985]
[PMID: 31484793]
[http://dx.doi.org/10.1016/S1474-4422(13)70310-7] [PMID: 24646875]
[http://dx.doi.org/10.1161/STROKEAHA.121.034498] [PMID: 34706562]
[http://dx.doi.org/10.1056/NEJMoa1813959] [PMID: 31091372]
[http://dx.doi.org/10.1056/NEJMoa1802686] [PMID: 29766772]
[http://dx.doi.org/10.1002/clc.22667] [PMID: 28273368]
[http://dx.doi.org/10.1016/S1474-4422(15)70027-X] [PMID: 25748102]
[http://dx.doi.org/10.1136/svn-2018-000143] [PMID: 30022801]
[http://dx.doi.org/10.1007/s11910-018-0871-1] [PMID: 30090997]
[http://dx.doi.org/10.1159/000476030] [PMID: 28654919]
[http://dx.doi.org/10.1001/jamaneurol.2019.0617] [PMID: 30958508]
[PMID: 29797853]
[http://dx.doi.org/10.1016/j.echo.2014.10.003] [PMID: 25559473]
[http://dx.doi.org/10.1093/eurheartj/ehaa612] [PMID: 32860505]
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2019.104390] [PMID: 31607440]
[http://dx.doi.org/10.1177/1747493019828648] [PMID: 30860455]
[http://dx.doi.org/10.1177/1747493016641967] [PMID: 27256472]
[http://dx.doi.org/10.1002/ana.26545] [PMID: 36373166]
[http://dx.doi.org/10.1177/23969873221099478] [PMID: 36082257]
[http://dx.doi.org/10.1093/ehjdh/ztac026] [PMID: 36712155]
[http://dx.doi.org/10.1016/j.ahj.2010.03.032] [PMID: 20598970]
[http://dx.doi.org/10.1212/WNL.0000000000012769] [PMID: 34504030]
[http://dx.doi.org/10.1161/STROKEAHA.109.552679] [PMID: 19461041]
[http://dx.doi.org/10.1212/WNL.0000000000006727] [PMID: 30530796]
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.06.019] [PMID: 26190307]
[http://dx.doi.org/10.3390/ijerph19127277] [PMID: 35742524]
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.028] [PMID: 29501269]
[http://dx.doi.org/10.1177/1756286419842698]
[http://dx.doi.org/10.1111/ene.15102] [PMID: 34519135]
[http://dx.doi.org/10.7150/ijms.9.108] [PMID: 22211098]
[http://dx.doi.org/10.1016/j.ipej.2016.10.002] [PMID: 27924760]
[PMID: 30595848]
[http://dx.doi.org/10.1161/STROKEAHA.115.008714] [PMID: 25700289]
[http://dx.doi.org/10.5551/jat.58420] [PMID: 32801289]
[PMID: 27075168]
[http://dx.doi.org/10.3389/fneur.2020.00026] [PMID: 32117002]
[http://dx.doi.org/10.1016/j.jacc.2005.08.077] [PMID: 16516087]